Echo Health Ventures

Echo Health Ventures is a venture capital firm that invests in healthcare companies, health technology, insurance technology and digital health in the United States. Based in Seattle with offices in Durham and Portland, the firm is stage-agnostic and aims to accelerate healthcare innovations to scale nationally by offering strategic guidance in addition to capital. Echo Health Ventures focuses on building deep, high-value relationships with portfolio companies to support growth and clinical impact, partnering with startups to advance patient care, improve care delivery, and broaden access to digital health tools.

Troy Arnold

Managing Principal, Echo Health Advisors

Karim Botros

Managing Partner, Strategic Investment

Lindsey Brown

Senior Associate, Strategic Investment

Robert Dolan

Managing Principal, Echo Health Advisors

Jon Eide

Managing Partner and COO

Ryan Gillooly

Principal

David Goad

Senior Associate, Strategic Investment

Jose Guerola

Principal, Strategic Investment

Matt Holman

Principal, Market Developement

Dusty Lieb

Partner

Maura Little

Managing Principal

Suzanne McLemore

Managing Partner and Head of Echo Health Advisors

Anahita Nakhjiri

Associate

Matt Parmett

Principal

Kurt Sheline

Principal

Pia Shivdasani Ph.D

Associate Principal, Echo Health Advisors

Anisha Sood

Partner

Annie Weissbach

Senior Associate, Strategic Investment

Jessica A. Zeaske

Partner

Past deals in Health Care

Vori Health

Series B in 2025
Vori Health offers an integrated medical practice specializing in treating musculoskeletal conditions. Its nationwide, evidence-based approach addresses back, neck, and joint issues through a unique, virtual-first care model. Patients are connected to a collaborative team consisting of a board-certified physician, health coach navigator, and physical therapist for comprehensive care.

Thyme Care

Series C in 2024
Thyme Care is a healthcare company specializing in oncology care management services. It offers an integrated solution for patients and providers, partnering with health plans to deliver comprehensive, personalized support to cancer patients.

Thyme Care

Venture Round in 2024
Thyme Care is a healthcare company specializing in oncology care management services. It offers an integrated solution for patients and providers, partnering with health plans to deliver comprehensive, personalized support to cancer patients.

Eleanor Health

Venture Round in 2024
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Founded in 2019 and headquartered in Waltham, Massachusetts, Eleanor offers comprehensive, whole-person care for mental health and substance misuse. The company operates a network of outpatient clinics and also provides virtual care as well as support in patients' homes and communities. Its services include medication-assisted treatment, evidence-based outpatient care, behavioral health services, and personalized recovery plans, all aimed at facilitating a faster recovery process for individuals suffering from substance abuse disorder.

Octave

Series B in 2023
Octave is a clinical platform developer focused on transforming the care landscape for multiple sclerosis and other neurodegenerative diseases. The company creates a platform that generates, analyzes, and integrates data to improve patient outcomes and reduce overall healthcare costs. By optimizing medication usage and healthcare services, Octave aims to enhance the efficiency of the pharmaceutical industry throughout the entire lifecycle of drug development, which includes discovery, clinical trials, and post-marketing phases. Their approach utilizes real-world evidence to inform decision-making, ultimately striving to set a new standard in multiple sclerosis care.

Upfront Healthcare Services

Series C in 2022
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.

Waltz Health

Series A in 2022
Waltz Health is a company focused on innovating the pharmaceutical supply chain by developing technology-driven solutions for pricing, distribution, and prescription of medications. It collaborates with various partners, including consumers, payers, and pharmacies, to create smarter ways to manage prescription care. The company utilizes AI-driven marketplaces to reduce costs and offers consumer tools that enhance decision-making regarding healthcare. These tools provide users with better pricing, comprehensive information, and resources aimed at lowering expenses, empowering consumers, and enabling payers to effectively manage their pharmacy benefits. Through these efforts, Waltz Health strives to improve the overall experience and affordability of prescription medications.

Wildflower Health

Venture Round in 2022
Founded in 2012, Wildflower Health is a San Francisco-based company that specializes in smartphone-based health programs. It offers Due Date Plus for maternity care and GROW for family health, providing services such as reminders, provider look-up, and health risk assessments to support users and connect them with healthcare providers.

Vori Health

Series A in 2021
Vori Health offers an integrated medical practice specializing in treating musculoskeletal conditions. Its nationwide, evidence-based approach addresses back, neck, and joint issues through a unique, virtual-first care model. Patients are connected to a collaborative team consisting of a board-certified physician, health coach navigator, and physical therapist for comprehensive care.

Eleanor Health

Series B in 2021
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Founded in 2019 and headquartered in Waltham, Massachusetts, Eleanor offers comprehensive, whole-person care for mental health and substance misuse. The company operates a network of outpatient clinics and also provides virtual care as well as support in patients' homes and communities. Its services include medication-assisted treatment, evidence-based outpatient care, behavioral health services, and personalized recovery plans, all aimed at facilitating a faster recovery process for individuals suffering from substance abuse disorder.

Cityblock

Series C in 2021
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Octave

Series B in 2020
Octave is a clinical platform developer focused on transforming the care landscape for multiple sclerosis and other neurodegenerative diseases. The company creates a platform that generates, analyzes, and integrates data to improve patient outcomes and reduce overall healthcare costs. By optimizing medication usage and healthcare services, Octave aims to enhance the efficiency of the pharmaceutical industry throughout the entire lifecycle of drug development, which includes discovery, clinical trials, and post-marketing phases. Their approach utilizes real-world evidence to inform decision-making, ultimately striving to set a new standard in multiple sclerosis care.

Upfront Healthcare Services

Series B in 2020
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.

Cityblock

Series B in 2020
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Aitia

Series D in 2019
Aitia is a leader in the application of Causal AI and Digital Twins focused on advancing drug discovery and development. The company utilizes machine learning and the convergence of multi-omic patient data to create Digital Twins that replicate the biological mechanisms of diseases. This innovative approach is particularly impactful in areas such as oncology, neurodegenerative disorders, and immunology. Aitia's Gemini Digital Twins are currently employed to identify novel therapies and expedite research and development in various conditions, including multiple myeloma, prostate cancer, Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease, with additional projects underway. The company collaborates with several prominent pharmaceutical firms, academic institutions, medical societies, and patient advocacy groups worldwide, thereby enhancing the potential for breakthroughs in medicine.

Cityblock

Series B in 2019
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Octave

Series A in 2018
Octave is a clinical platform developer focused on transforming the care landscape for multiple sclerosis and other neurodegenerative diseases. The company creates a platform that generates, analyzes, and integrates data to improve patient outcomes and reduce overall healthcare costs. By optimizing medication usage and healthcare services, Octave aims to enhance the efficiency of the pharmaceutical industry throughout the entire lifecycle of drug development, which includes discovery, clinical trials, and post-marketing phases. Their approach utilizes real-world evidence to inform decision-making, ultimately striving to set a new standard in multiple sclerosis care.

Wildflower Health

Series C in 2018
Founded in 2012, Wildflower Health is a San Francisco-based company that specializes in smartphone-based health programs. It offers Due Date Plus for maternity care and GROW for family health, providing services such as reminders, provider look-up, and health risk assessments to support users and connect them with healthcare providers.

Upfront Healthcare Services

Series A in 2017
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.

Phreesia

Series B in 2007
Phreesia is a technology company focused on enhancing patient care experiences. It replaces traditional clipboard-based check-in processes with secure, wireless touchscreen devices that collect patient information compatible with electronic medical records. Phreesia improves operational efficiency and patient satisfaction by automating administrative tasks, providing relevant health education, and facilitating seamless data transfer between patients' previous visits.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.